Compare Hinge Health Inc. Class A Common Stock (HNGE) vs Lucid Group Inc (LCID) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hinge Health Inc. Class A Common Stock vs Lucid Group Inc — how do they compare? Hinge Health Inc. Class A Common Stock trades at $103.99 (market cap $8.47B), while Lucid Group Inc trades at $3.27 (market cap $1.30B). The key difference: Hinge Health Inc. Class A Common Stock is far larger — about 6.5× Lucid Group Inc's market cap, and Hinge Health Inc. Class A Common Stock is trading nearer its 52-week high, Lucid Group Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and Lucid Group Inc for 45 Days on average.
| HNGE | LCID | |
|---|---|---|
Market Cap | $8.47B | $1.30B |
Volume | 1,624,526 | 16,941,666 |
Sector | Health | Consumer Cyclical |
52-Week High | $105.14 | $21.67 |
52-Week Low | $31.17 | $3.29 |
Typical Hold Time | 0 Days | 45 Days |
Enterprise Value | $8.09B | $4.19B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Lucid Group (LCID) trades at $3.36, down 2.33% amid ongoing operational challenges. The stock shows bearish technical signals with all moving averages indicating selling pressure, though oversold RSI levels suggest potential near-term bounce. Fundamentally, the company continues to burn cash with negative gross margins of -96.56% and widening losses, while recent news highlights delayed product launches and aggressive cost-cutting initiatives targeting $1.4 billion in savings.
LCID faces significant headwinds with persistent losses and cash burn threatening viability, though strategic partnerships and cost reduction efforts provide some optimism. The stock trades at deep discounts to sales and book value, but requires successful execution on new vehicle launches and substantial margin improvement to justify analyst consensus price target of $7.00, representing 109% upside from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →About Lucid Group Inc
Lucid Group Inc is a technology and automotive company. It develops the next generation of electric vehicle (EV) technologies. It is a vertically integrated company that designs, engineers, and builds electric vehicles, EV powertrains, and battery systems in-house using our own equipment and factory.
Read more on LCID →
